Department of Radiology
Found 12 results
Filters: Keyword is Neoplasm Recurrence, Local  [Clear All Filters]
2023
Limberg J, Egan CE, Gray KD, Singh M, Loewenstein Z, Yang Y, Riascos MCristina, Asadi HAl, Safe P, Eshaky SEl et al..  2023.  Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma.. Mol Cancer Res. 21(5):397-410.
De Martino M, Daviaud C, Minns HE, Lazarian A, Wacker A, Costa APaula, Attarwala N, Chen Q, Choi S-W, Rabadàn R et al..  2023.  Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma.. Cancer Lett. 570:216329.
2022
Bellat V, Michel AO, Thomas C, Stokol T, Choi BB, Law B.  2022.  A Urinary Drug-Disposing Approach as an Alternative to Intravesical Chemotherapy for Treating Nonmuscle Invasive Bladder Cancer.. Cancer Res. 82(7):1409-1422.
2019
Ivanidze J, Roytman M, Lin E, Magge RS, Pisapia DJ, Liechty B, Karakatsanis N, Ramakrishna R, Knisely J, Schwartz TH et al..  2019.  Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas.. J Neuroimaging. 29(5):650-656.
Ramchandani D, Lee SKoo, Yomtoubian S, Han MShin, Tung C-H, Mittal V.  2019.  Nanoparticle Delivery of miR-708 Mimetic Impairs Breast Cancer Metastasis.. Mol Cancer Ther. 18(3):579-591.
2017
Chiang GC, Galla N, Ferraro R, Kovanlikaya I.  2017.  The Added Prognostic Value of Metabolic Tumor Size on FDG-PET at First Suspected Recurrence of Glioblastoma Multiforme.. J Neuroimaging. 27(2):243-247.
Galla N, Chiang G, Chakraborty S, Singh R, A Tsiouris J, Boockvar J, Kovanlikaya I.  2017.  Apparent diffusion coefficient changes predict survival after intra-arterial bevacizumab treatment in recurrent glioblastoma.. Neuroradiology. 59(5):499-505.
2016
A Wernicke G, Lazow SP, Taube S, Yondorf MZ, Kovanlikaya I, Nori D, Christos P, Boockvar JA, Pannullo S, Stieg PE et al..  2016.  Surgical Technique and Clinically Relevant Resection Cavity Dynamics Following Implantation of Cesium-131 (Cs-131) Brachytherapy in Patients With Brain Metastases.. Oper Neurosurg (Hagerstown). 12(1):49-60.
2012
Schoellnast H, Deodhar A, Hsu M, Moskowitz C, Nehmeh SA, Thornton RH, Sofocleous CT, Alago W, Downey RJ, Azzoli CG et al..  2012.  Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy.. Acta Radiol. 53(8):893-9.
2011
Schoellnast H, Larson SM, Nehmeh SA, Carrasquillo JA, Thornton RH, Solomon SB.  2011.  Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.. Cardiovasc Intervent Radiol. 34 Suppl 2:S182-5.
Boockvar JA, Tsiouris AJ, Hofstetter CP, Kovanlikaya I, Fralin S, Kesavabhotla K, Seedial SM, Pannullo SC, Schwartz TH, Stieg P et al..  2011.  Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article.. J Neurosurg. 114(3):624-32.
2004
Pucar D, Koutcher JA, Shah A, Dyke JP, Schwartz L, Thaler H, Kurhanewicz J, Scardino PT, W Kelly K, Hricak H et al..  2004.  Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse.. Clin Prostate Cancer. 3(3):174-81.